TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded without competitionContract termination notice
Published 21 May 2025, 10:55 BST

Official UK procurement notice

ADCETRIS (BRENTUXIMAB VEDOTIN) 50MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 1 each

Official notice

Authority: Belfast Health and Social Care Trust (Central government)

Direct award
Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)
Awarded value£700,000published award · exc. VAT
Awarded 21 May 2025no call for competition
Awarded to Alloga UK

What is being bought

Published requirement description

PROCUREMENT OF ADCETRIS (BRENTUXIMAB VEDOTIN) 50MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 1 each

The lotProcurement structure

single lot · no lot value published
Lot #1Awarded
Delivery: Northern Ireland
33600000 Pharmaceutical products

Procedure terms & legal framework

From the official record
Procedure method
Direct award
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
21 May 2025, 10:55 BST
Last source update
8 Oct 2026, 14:29 BST
Authority reference
DACPM2025-27
FTS notice number
2026/S 000-095268
Latest notice
Contract termination notice (UK11)
Delivery area
Northern Ireland (UKN)
Official registry OCID
ocds-h6vhtk-051a10 Find a Tender
Why no open competition
Single Suppliers Intellectual Property Exclusive Rights
Published justification

These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

How it was run

Official notice
Submission deadline
—

Timeline

2 Jun 2025 → 8 Oct 2026 · 2 dates
  1. Standstill ends
    2 Jun 2025, 23:59 BST
  2. Notice published14 days ago
    8 Oct 2026, 14:29 BST

Notice history

5 events · 4 releases on Find a Tender · since 21 May 2025
  1. Transparency notice published
    21 May 2025, 10:55 BST
    UK5
  2. Contract award notice published
    21 May 2025, 10:59 BST
    UK6
  3. Contract details notice published
    6 Jun 2025, 14:15 BST
    UK7
  4. Contract signature expected
    16 Jun 2025, 23:59 BST
    scheduled
  5. Contract termination notice published
    8 Oct 2026, 14:29 BST
    UK11
Routine re-releases (4)
  • 2025-05: 1 release · 21 May 2025

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £700,0001 award exc. VAT
Contracts signed 1latest 3 Jun 2025
Awarded toValueDateStatus
Alloga UKADCETRIS (BRENTUXIMAB VEDOTIN) 50MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1 vial17 Jun 2025 – 30 Jun 2027£700,00021 May 2025Awarded

Contracts

  • ADCETRIS (BRENTUXIMAB VEDOTIN) 50MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1 vial · Alloga UK

    Signed
    3 Jun 2025
    Value
    £700,000
    Period
    3 Jun 2025 – 30 Jun 2027
    Status
    terminated
    Final value
    £700,000
    Termination
    other

    No agreed KPIs: Contract value is below the relevant threshold for Key perfomance indicators

Contracting authority & participating public bodies

Belfast Health & Social Care Trust

Contracting authorityPublic authority - central governmentNorthern Irish devolved regulations apply GB-PPON: PLQJ-5727-JCLR Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital, Belfast, Northern Ireland, BT12 6BAContact email

Bidders & participating suppliers

1 commercial party on the notice
  • ALLOGA UK LIMITEDAwarded supplierGB-COH: 03169255GB-PPON: PBTH-6754-GVPN Amber Park, Alfreton, East Midlands, DE55 2FHContact email

Official documents & specifications (4)

Official links; attachments are not copied

Notices published for this procedure